ArticleFrontiers in neurology2025

Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.

Eduardo Agüera-Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.